Shout-Out: M&N’s Pizza - Bethesda, MD
/
Every so often you happen upon that book, artwork, shop, restaurant, hotel or museum that strikes a particular chord…
Read More
Latest News
Letter from the Editor
/
Just slightly less than 30 years ago, in December 1992, injectable sumatriptan (Imitrex) was approved by the FDA for the treatment of acute migraine headache…
Read MoreFor those who prefer to read the Summer 2022 issue's feature article in Portuguese...
/
Na prática médica e especificamente na prática cefaliátrica, as seguradoras geralmente requerem autorizações prévias (AP) antes de reembolsar ou pagar o paciente ou o provedor de serviços como a clínica de exames ou de tratamento como no botox…
Read MoreDancing With the Devil: A Physician’s Perspective
/
In the practice of medicine generally and headache medicine specifically, insurers often require “prior authorization” (PA) before they will reimburse…
Read MoreMono-therapy vs Polytherapy: When is Two Better Than One?
/
In the last issue of this magazine we focused on the relative attractiveness of the “old” medications for migraine treatment compared to the newer “designer drugs”…
Read MoreWhat’s New? Developments from the front lines of migraine research
/
Atogepant (Qulipta): an attractive new option for suppressing chronic migraine
Migraine “Rescue”: don’t like self-injection? how about a nasal spray?
Alzheimer’s, Dementia and Migraine: where things presently stand
Migraine and Sex: an update and a stimulating(!) new avenue of research
Lagniappe: A Gift: The Chesapeake and Ohio (C&O) Canal
/
The Chesapeake and Ohio (C&O) Canal was conceived by George Washington, the ever-entrepreneurial Father of Our Country, as a means of…
Read MoreMigraine Treatment of the Month: Divalproex sodium: an oldie... but a goodie?
/
In 1978 valproic acid (also known as sodium valproate or divalproex sodium) was approved by the FDA for seizure prevention…
Read MoreMigraine Myth of the Month: The triptans are potentially dangerous drugs
/
The first “designer drug” for migraine treatment, injectable sumatriptan (Imitrex), was approved by the FDA for general clinical use in this country in 1992…
Read MoreDoctor on Call: What the heck is “transformed migraine”?
/
Sandra, a 37-year-old computer software engineer and mother of three from Colorado Springs, writes:
Read MoreBiographies
/It is my great pleasure to announce to our readership that Drs. Robert Cowan and Richard Lipton have accepted my invitations to become senior editorial advisers.
Read MoreMessages to the Editor
/
Addressing the article entitled “Migraine’s Supply/Demand Problem” in our Spring 2022 issue Ms. Pam Nice writes…
Read MoreLetter from the Editor
/
After a gorgeous spring, western Maryland gave way to an equally gorgeous summer…
Read MoreMigraine’s “Supply:Demand” Problem...and How to Fix it: A public health bottleneck
/
Very few chronic medical disorders exert more…
Read MoreNon-Pharmacologic Treatment of Migraine: What YOU can do to reduce your migraine burden
/
Many of the newer medications for prevention of episodic migraine, suppression of chronic migraine and treatment of acute migraine headache are…
Read MoreMigraine Myth of the Month: Every Migraineur Needs to See a Healthcare Provider?
/
For a number of reasons I’ve long have had a problem reading papers published in the medical literature…
Read MoreMigraine Tip of the Month: Assess and Reduce Your Level of Stress
/
In this issue we have focused a fair amount of attention on how stress and migraine may interact…
Read MoreDoctor on Call
/
Janet, a 37-year-old female legal assistant and married mother of three who lives in Charlotte writes…
Read MoreLetter from the Editor
/
If you’re like me, Spring 2022 may be a time marked by cautious optimism uneasily blended with a grim sense of foreboding…
Read More
